StockWatch
·

PPAP Automotive Limited Q2 FY27 Results

PPAPQ2 FY27 Results
Filing
Result:Good· Market: Up#Turnaround#Base effect#Margin squeeze

Outlook: Cautiously Optimistic · Guidance: None

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue177.8313.7%29.8%
Total Income179.1013.0%30.6%
Expenditure175.8011.7%28.1%
PBT3.31185.9%4003.7%
Net Profit2.47185.8%5525.2%
OPM8.81%0.88pp0.48pp
NPM1.38%0.83pp1.41pp
EPS1.75186.9%5733.3%
View full financials

Revenue grew a strong 29.8% YoY to a 6-quarter high and PAT turned around from a near-breakeven loss, but consolidated OPM slipped YoY to 8.8% (from 9.3%) and remains well below management's 12-13% target, so the turnaround is tempered by margin squeeze and a depressed prior-year base rather than a clean beat.

PPAP AUTOMOTIVE LIMITED · Q2 FY-2027 · THE VERDICT

Order book is real, but margin recovery is not yet proven

PPAP reported ₹177.8 Cr revenue (+29.8% YoY), but gross margin compressed 680 basis points and net profit jumped on a low prior-year base. The order book of ₹429 Cr (lifetime) is genuine—but profitability recovery now hinges on cost pass-through in H2, missing the prior Q2–Q3 guidance.

16 Nov 2026 · 6 min read

The tension: headline profit vs. operational reality

Reported PAT

₹2.5 Cr

+5525% YoY

vs. prior year base

₹0.05 Cr loss

Leverage effect, not margin

NPM delivered

1.4%

vs 12–13% target

Gross margin

39.8%

was 45.6%; −680 bps

The +5525% PAT growth looks like a blowout until you see the denominator: ₹0.05 Cr loss in the prior quarter. PPAP's profitability recovery is a leverage effect—higher revenue (₹177.8 Cr, +29.8% YoY) spreading fixed costs over a larger base—not operational margin expansion. The real story is the 680-basis-point compression in gross margin (45.6% down to 39.8%), driven by raw material volatility and unfavorable product mix, and the company's unfulfilled commitment to recover margin by Q2–Q3 FY27.

Management's claims vs. what holds up

  • "Record quarterly revenue supported by strong customer demand"

  • ₹177.8 Cr, +29.8% YoY; highest ever Q2 sales

  • "Margin recovery by Q2–Q3 FY27 if cost negotiations settle"

  • Delivered: gross margin compressed; OPM 8.8% vs 12–13% target. Recovery deferred to H2.

  • "Capacity utilization moving toward 80–82% target"

  • 78% Q2 vs 68% prior year Q2; on track, not yet at target.

  • "Lifetime order book ₹429 Cr, with ₹300 Cr added Q2 alone"

  • Confirmed; 2–4 year execution window. EV orders ₹156.5 Cr (36% of total).

  • "EV order book growth reflects strong EV adoption momentum"

  • EV orders ₹156.5 Cr H1 vs ₹127 Cr prior (~23% growth, not "6x"). Phrasing likely refers to Q2 new wins alone.

The margin guidance miss is the headline failure: management had committed to margin recovery by Q2–Q3 contingent on cost negotiations, but Q2 delivered the opposite (−680 bps compression). CFO Sachin Jain acknowledged this in the Q&A, stating that 68% of cost increases have been recovered from customers and the remaining 32% is "in process" with a 6-month lag forecast to realize in H2 FY27. The order book, capacity progress, and revenue growth are all real—but they're offset by a profitability shortfall that now rides on H2 execution.

What changed on this call

Q1 call guidance vs. Q2 delivery

Margin recovery

Q2 delivery or reset

Deferred to H2 FY27; 68% recovered, 32% pending

Signal

⬇ Downgrade

By Q2–Q3 if cost negotiations settle

Order book

Q2 delivery or reset

₹429 Cr lifetime H1; ₹300 Cr Q2 alone; EV ₹156.5 Cr

Signal

⬆ Upgrade

Track record of wins

Capacity expansion

Q2 delivery or reset

Q3 FY27 operational confirmed; 78% utilization (vs 68% prior year)

Signal

⬆ Accelerated

Chennai plant Q3 'based on demand'

Aftermarket target

Q2 delivery or reset

Currently 5%, +24% YoY. 154 distributors in place. Unchanged multi-year aspiration.

Signal

→ Neutral

10% of revenue (multi-year)

The key downgrade is the margin timeline: from Q2–Q3 to H2. The key upgrades are the order book (now quantified at ₹429 Cr lifetime vs. prior vague forward commentary) and capacity execution (Chennai Q3 confirmed). Aftermarket is progressing (+24% YoY, 154 distributors), but the 10% revenue target is clearly multi-year, not near-term.

Earnings quality: where the profit sits

Earnings quality flags

Gross margin compression unrecovered

HIGH

680 bps compression Q2 vs prior year; driven by raw material cost + product mix (more battery/tooling sales). Pass-through mechanism claimed but 32% still pending with 6-month lag into H2.

PAT recovery on low base, leverage effect

MEDIUM

Prior year was ₹0.05 Cr loss; Q2 ₹2.5 Cr profit is a denominator effect, not margin expansion. NPM 1.4% vs sustainable target; shows fixed-cost absorption, not operational margin strength.

EBITDA improvement unquantified forward

MEDIUM

CFO Payal Shah asked for H2 EBITDA margin guidance; answer was 'difficult to quantify due to Western disturbance, raw material volatility.' Limits credibility of recovery claim—no specific number to benchmark.

EV order growth phrasing '6x' vague

LOW

Call phrasing 'substantial growth' and press release '6x growth' in EV orders misleading. H1 YoY arithmetic is ~23% (₹156.5 Cr vs ₹127 Cr prior year). Likely refers to Q2 new orders alone. Minor clarity issue.

The bull-bear ledger

Two-sided case
  • ✓ Order book strength: ₹429 Cr lifetime (2–4 year visibility). Maruti, Tata, JSW, MG Motors, VinFast confirmed. 36% in EV.

  • ✓ Revenue growth outpacing market: +29.8% YoY on 18.2% domestic vehicle sales growth. Volume leverage evident.

  • ✓ Capacity ramp on track: 78% utilization (toward 82% target). Chennai plant Q3 operational. Supports order execution.

  • ✓ EV exposure embedded: ₹156.5 Cr of ₹429 Cr order book; provides long-term optionality as EV adoption accelerates.

  • ✗ Gross margin compression 680 bps unrecovered. Target 12–13% OPM, delivered 8.8% Q2.

  • ✗ Margin recovery guidance missed: Q1 call promised Q2–Q3 recovery. Q2 delivered -680 bps instead. Credibility hit.

  • ✗ Cost pass-through mechanism incomplete: 68% recovered, 32% pending with 6-month lag. If raw material spikes again, recovery window narrows.

  • ✗ PAT recovery on low base: ₹2.5 Cr profit from ₹0.05 Cr loss is leverage, not margin strength. NPM 1.4% vs 12–13% target.

  • ✗ Aftermarket still early-stage: 5% of revenue (target 10%). Capital-intensive distribution expansion; multi-year ramp.

Risks, ranked by how much they should concern a holder

Ranked risks

Margin recovery delay or failure

HIGH

Gross margin compressed 680 bps; pass-through mechanism only 68% complete. If 32% pending recovery stalls or raw material prices spike again, margin recovery window closes. Q1 guidance miss reduces credibility of H2 recovery claim.

Order book execution slippage

MEDIUM

₹429 Cr lifetime orders execute over 2–4 years. Any OEM platform delay or volume reduction impacts revenue visibility. Customer concentration risk (Maruti, Tata, JSW) if demand slows.

EV adoption timing mismatch

MEDIUM

EV orders ₹156.5 Cr (36% of total) but EV penetration in India still sub-5%. Order conversion contingent on OEM vehicle launch pace and market adoption speed, which is uncertain.

Raw material price volatility persistence

MEDIUM

Western disturbance cited as ongoing headwind. If steel, aluminium, oil prices remain elevated, the 6-month lag in price pass-through means margin pressure persists through H2 and beyond.

Aftermarket scale-up capital intensity

LOW

Aftermarket at 5% revenue; 10% target multi-year. Requires sustained 20%+ YoY growth for 2–3 years, funded through distribution expansion, warehousing, and brand building. Capital-heavy; execution risk.

How the market is positioned

PPAP trades at ₹252 as of 2026-11-16, sitting above key moving averages (SMA20 ₹226.68, SMA50 ₹235.67, SMA200 ₹234.38) in a bullish trend. RSI at 59 is neutral—no overbought signal. The stock has recovered 43% off its 52-week low (₹176) but remains 65% below its all-time high (₹723.1), indicating significant prior pessimism and partial recovery. Volume is increasing, suggesting growing retail/institutional interest.

Ownership structure is stable but FII trimming is a subtle warning: Promoter holding 64.30% (unchanged), FII 5.66% (down 18 basis points QoQ), DII 0.00% (no activity). The FII reduction, while small, suggests institutional investors are neither accumulating on strength nor building positions ahead of margin recovery—a tepid stance that matches the fundamental "show me" dynamic.

Bulk/block deal activity is clean: July 2026 saw typical arbitrage trades (GM bulk buy/sell around ₹326–₹329) and research-firm positions (NK Securities, Indra Kiran Ventures around ₹235–₹246). No promoter or insider selling near the highs (₹379.5). No red flag on insider conviction.

Market verdict on the print: The stock's post-result behavior (bullish trend above moving averages, increasing volume, but FII slight trim) suggests cautious optimism: the market is acknowledging order book strength and revenue growth, but not giving PPAP the benefit of the doubt on margin recovery until H2 proves it. The 65% drawdown from ATH is still the dominant narrative—this is a stock the market is rebuilding confidence in, not one accelerating to new highs.

What to watch next

Concrete catalysts and milestones
  • 1 · Q3 FY27 (Dec 2026): Chennai plant operational + capacity utilization progress

    Chennai plant is scheduled to go operational in Q3. Watch for capacity utilization progression toward 80–82% target and first revenue contribution from the new facility. This is the execution proof point for capacity ramp and order conversion.

  • 2 · H2 FY27 (Jan–Mar 2027): Cost pass-through realization

    The critical inflection. Management claims 32% of cost increases will settle in H2 with a 6-month lag from negotiation. Watch Q3 gross margin and EBITDA margin for evidence of recovery. This is the make-or-break for the entire margin recovery narrative.

  • 3 · Q4 FY27: Hutchinson partnership first commercial order + aftermarket progress

    First commercial order from Hutchinson body sealing tech partnership expected Q4. This is a higher-margin, new technology revenue stream. Also track aftermarket scale: 154 distributors, 2 new regional warehouses planned (North, South, West, East). Progress here would validate the diversification play.

The number to track from here

Gross margin in Q3 FY27. Everything rides on this. If Q3 gross margin recovers even to 42–43% (a move toward the 45.6% target), the cost pass-through narrative is validated and H2 recovery is real. If Q3 margin stays at 39–40%, the 6-month lag claim is suspect and the margin recovery window extends further into FY28. This single line item will determine whether the street's cautious optimism (FII stable, stock above averages, but no new highs) becomes conviction.

PPAP has delivered the order book it promised (₹429 Cr), executed on revenue growth (29.8% YoY), and is on track with capacity expansion (78% toward 82%). But it has also failed its Q2–Q3 margin recovery guidance and delivered operational profit at less than 1/10th of target. This is not a step-change improvement, and it is not a margin-expansion story yet. It is a high-growth, low-profitability transition phase, where execution on cost recovery in H2 FY27 will separate belief from hope. Hold for now, but the credibility bar for the next call is high: show H2 gross margin recovery (toward 43%+), and PPAP moves from "cautiously optimistic" to "upgrade candidate." Fail to recover, and the order book story will be priced as a 2–4 year visibility play, not a near-term profitability recovery.

Informational and educational content only. Not investment advice.